Skip to main content
. 2012 Jun 1;4(3):284–291. doi: 10.3978/j.issn.2072-1439.2012.02.04

Table 3. Trends in resistance rate of Acinetobacter to antibiotics, 2006 to 2010.

Antibiotics 2006 2007 2008 2009 2010 R2 P 95% CI Trend
Ceftazidime
 65.8
 69.3
 61.2
 83.6
 93.3
 0.67
 0.09
 –1.99-15.85
 Stable
Ceftriaxone
 71.0
 93.5
 87.8
 96.1
 98.8
 0.69
 0.08
 –1.35-12.99
 Stable
Cefepime
 51.5
 56.2
 51.1
 76.6
 88.2
 0.78
 0.05
 0.28-18.48
 Increasing
Aztreonam
 55.2
 54.3
 61.3
 84.3
 87.4
 0.86
 0.02
 2.42-16.46
 Increasing
Imipenem
 14.4
 17.0
 13.9
 60.2
 86.3
 0.79
 0.04
 1.20-36.20
 Increasing
Meropenem
 18.9
 35.5
 23.4
 59.4
 87.1
 0.80
 0.04
 1.24-30.82
 Increasing
Amoxicillin/clavulanate
 71.1
 75.9
 61.7
 84.7
 94.3
 0.49
 0.19
 –4.91-15.95
 Stable
Piperacillin/tazobactam
 51.0
 57.4
 52.8
 82.2
 91.3
 0.81
 0.04
 1.16-19.92
 Increasing
Cefoperazone/sulbactam
 8.8
 13.0
 10.6
 43.8
 55.4
 0.82
 0.04
 1.61-23.19
 Increasing
Amoxicillin
 55.8
 59.8
 57.7
 69.6
 75.1
 0.84
 0.03
 0 .98-8.70
 Increasing
Ciprofloxacin
 55.6
 87.5
 66.7
 100.0
 82.1
 0.35
 0.29
 –9.79-22.89
 Stable
Levofloxacin 61.5 57.8 58.1 75.4 80.1 0.69 0.08 –1.27-12.23 Stable